Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Low-dose fluoxetine therapy for depression.

× No keyword cloud information.

21 in total

Review 1. Therapeutic drug monitoring of antidepressants: cost implications and relevance to clinical practice.

Authors: M J Burke; S H Preskorn
Journal: Clin Pharmacokinet Date: 1999-08 Impact factor: 6.447

Review 2. Randomized, placebo-controlled trials of antidepressants for acute major depression: thirty-year meta-analytic review.

Authors: Juan Undurraga; Ross J Baldessarini
Journal: Neuropsychopharmacology Date: 2011-12-14 Impact factor: 7.853

3. Comparative efficacy and durability of continuation phase cognitive therapy for preventing recurrent depression: design of a double-blinded, fluoxetine- and pill placebo-controlled, randomized trial with 2-year follow-up.

Authors: Robin B Jarrett; Michael E Thase
Journal: Contemp Clin Trials Date: 2010-05-06 Impact factor: 2.226

4. Does study design influence outcome?. The effects of placebo control and treatment duration in antidepressant trials.

Authors: Bret R Rutherford; Joel R Sneed; Steven P Roose
Journal: Psychother Psychosom Date: 2009-03-24 Impact factor: 17.659

Review 5. Differences in adverse effect reporting in placebo groups in SSRI and tricyclic antidepressant trials: a systematic review and meta-analysis.

Authors: Winfried Rief; Yvonne Nestoriuc; Anna von Lilienfeld-Toal; Imis Dogan; Franziska Schreiber; Stefan G Hofmann; Arthur J Barsky; Jerry Avorn
Journal: Drug Saf Date: 2009 Impact factor: 5.606

6. Does differential drop-out explain the influence of study design on antidepressant response? A meta-analysis.

Authors: Bret R Rutherford; Joel R Sneed; Steven P Roose
Journal: J Affect Disord Date: 2012-03-02 Impact factor: 4.839

7. Preventing depressive relapse and recurrence in higher-risk cognitive therapy responders: a randomized trial of continuation phase cognitive therapy, fluoxetine, or matched pill placebo.

Authors: Robin B Jarrett; Abu Minhajuddin; Howard Gershenfeld; Edward S Friedman; Michael E Thase
Journal: JAMA Psychiatry Date: 2013-11 Impact factor: 21.596

8. Dose-response relationship of duloxetine in placebo-controlled clinical trials in patients with major depressive disorder.

Authors: Per Bech; Daniel K Kajdasz; Vibeke Porsdal
Journal: Psychopharmacology (Berl) Date: 2006-09-08 Impact factor: 4.530

Review 9. Treatment considerations for the depressed geriatric medical patient.

Authors: H G Koenig
Journal: Drugs Aging Date: 1991 Jul-Aug Impact factor: 3.923

10. The effects of antidepressant treatment on serum cytokines and nutritional status in hemodialysis patients.

Authors: Sang-Kyu Lee; Hong-Seock Lee; Tae-Byeong Lee; Do-Hoon Kim; Ja-Ryong Koo; Yong-Ku Kim; Bong-Ki Son
Journal: J Korean Med Sci Date: 2004-06 Impact factor: 2.153